Dr. Andrew Norden reveals his journey from Dana-Farber neuro-oncologist to OncoHealth's Chief Medical Officer, where he now oversees prior authorization decisions for cancer treatments that can cost $400,000 per patient. When the emotional toll of watching his brain cancer patients suffer became unbearable, Dr. Norden sought broader impact on the lives of cancer patients through technology that could identify and prevent inappropriate care - saving millions while preserving quality. In this candid conversation, he confronts healthcare's perverse incentives (where physicians earn more from prescribing expensive drugs regardless of benefit) and explains how AI is transforming utilization management from a bureaucratic hurdle into an invisible guardian of appropriate care. Gain insider perspective on the challengess at the intersection of cancer economics, physician autonomy, and patient outcomes.

Watch on YouTube

Follow on LinkedIn

Share This Episode with a Friend